Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Early research (Phase 1)Active Not RecruitingNCT05717348
What this trial is testing

ES014 in Patients With Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor
Elpiscience (Suzhou) Biopharma, Ltd. 120
Early research (Phase 1)Study completedNCT02833155
What this trial is testing

Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Taizhou EOC Pharma Co., Ltd. 19
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04021108
What this trial is testing

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Who this might be right for
Gastroesophageal Adenocarcinoma
Weill Medical College of Cornell University 80
Early research (Phase 1)UnknownNCT03282825
What this trial is testing

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Who this might be right for
Advanced Breast Cancer
Dong Wha Pharmaceutical Co. Ltd. 18
Early research (Phase 1)Study completedNCT00987376
What this trial is testing

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Not applicableStudy completedNCT06461689
What this trial is testing

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Central Hospital, Nancy, France 80
Testing effectiveness (Phase 2)Study completedNCT00425191
What this trial is testing

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sanofi 165
Early research (Phase 1)Active Not RecruitingNCT04526691
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Who this might be right for
Advanced or Metastatic NSCLC
Daiichi Sankyo 145
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Ended earlyNCT00996255
What this trial is testing

Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Nerviano Medical Sciences 19
Very early researchEnded earlyNCT03454243
What this trial is testing

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Looking for participantsNCT07486089
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)HER2-positive Breast CancerTriple-Negative Breast Cancer (TNBC)
Beijing Biotech 60
Testing effectiveness (Phase 2)Ended earlyNCT03367689
What this trial is testing

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent

Who this might be right for
Breast Cancer
MedSIR 7
Not applicableStudy completedNCT01729689
What this trial is testing

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers

Who this might be right for
Anxiety DisorderRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Stanford University 13
Testing effectiveness (Phase 2)Study completedNCT00033618
What this trial is testing

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more
National Cancer Institute (NCI) 144
Very early researchStudy completedNCT03928210
What this trial is testing

Digoxin Induced Dissolution of CTC Clusters

Who this might be right for
Breast CancerCirculating Tumor Cells (CTCs)
University Hospital, Basel, Switzerland 58
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Next Page